Monthly View Flat View Weekly View Daily View Categories


Event: 'CV Risk Reduction with SGLT2 Inhibitors and GLP-1 Receptor Agonists: Taking a Closer Look'

 

CME Satellite Symposium

Date: Friday, June 07, 2019 (06:30 PM-09:30 PM)
Duration: 3 Hour(s)
  URL: https://www4.cmrreg.com/ada2019/
  Location: San Francisco Marriott Marquis • Golden Gate Ballroom A&B, 780 Mission Street • San Francisco, California

In this program, leading diabetes experts ( Chair Dr. Lawrence Leiter, and faculty members Dr. David Cherney, Dr. Melanie Davies, Dr. Darren McGuire, and Davida Kruger, NP) - will provide state-of-the-art information on optimal management of patients with SGLT2 inhibitors and GLP-1 RAs, including latest guideline recommendations, expanding clinical trial evidence, emerging potential mechanistic concepts for cardio-renal benefits, and insights into patient-centered, collaborative care to improve outcomes.